Newcells Biotech Limited

#09389592 Active

Newcells Biotech specializes in developing functional in vitro models that enhance clinical translation and drug discovery, focusing on human tissue models for various applications.

Founded: 15 Jan 2015
Industries:
72110 - Research and experimental development on biotechnology
Location: Newcastle Upon Tyne

Products & Services

• biomedical research
• biotechnology company
• clinical translation
• disease modelling
• drug discovery
• drug transporter interactions
• gene therapy
• human lung fibroblasts
• human tissues
• in vitro models
• proximal tubule assay-ready plates
• retinal organoids

Financial Snapshot

Last accounts made up to 31 Jan 2025
Next accounts due 31 Oct 2026 (9 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
6
Shareholders
34
Controllers (PSC)
5
Michael John Nicholds
Director • British • Lives in England • Born in Jun 1960
Mercia Fund Management (nominees) Limited
Corporate Director • United Kingdom
Lyle Armstrong
Director • British • Lives in United Kingdom • Born in Apr 1965
Mark Carnegie-brown
Director • British • Lives in United Kingdom • Born in Aug 1960
Simon Andrew Berry
Director • British • Lives in United Kingdom • Born in Jan 1973

Registered Office Address

Time Central

32 Gallowgate

Newcastle Upon Tyne

NE1 4BF

United Kingdom

Basic Information

LTD
15 Jan 2015
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

12
Officers
5
PSCs
0
Filings